SKA2 and breast carcinoma: Taken together, our findings presented that NT21MP can regulate expression level of SPRY4-IT1 by blocking SDF-1α/CXCR4 axis and subsequently, activating SKA2 and playing a key role in breast cancer cell apoptosis (Figure 10).